Brief: Neubase Therapeutics Announces Gene Editing Research Agreement With Global Healthcare Company
21/10/2022 13:05
Oct 21 (Reuters) - NeuBase Therapeutics Inc NBSE.O :
* NEUBASE THERAPEUTICS ANNOUNCES GENE EDITING RESEARCH
AGREEMENT
WITH GLOBAL HEALTHCARE COMPANY
* NEUBASE THERAPEUTICS - FOR RESEARCH, HEALTHCARE COMPANY
WILL
EVALUATE NEUBASE'S PATROL TECHNOLOGY FOR THREE MONOGENIC GENETIC
DISEASES
* NEUBASE THERAPEUTICS - CO AND HEALTHCARE COMPANY WILL
COLLABORATE ON EVALUATION OF DRUG CANDIDATES FOR THREE
UNDISCLOSED INDICATIONS
* NEUBASE THERAPEUTICS - HEALTHCARE CO TO HAVE EXCLUSIVE
OPPORTUNITY, TO LICENSE & DEVELOP DRUG CANDIDATES CREATED UNDER
RESEARCH EVALUATION AGREEMENT
Source text for Eikon: ID:nGNX6YVsjP
Further company coverage: NBSE.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NeuBase Therapeutics
See all newsBrief: Neubase Therapeutics, On May 2, Was Notified By Nasdaq On Not Regained Compliance With Minimum Bid Price Requirement
Brief: Neubase Therapeutics Announces Receipt Of Notice From Nasdaq
U.S. STOCKS ON THE MOVE-TPG, R1 RCM, Zoom
U.S. STOCKS ON THE MOVE-Micron, Krystal Biotech, Pilgrim's Pride
U.S. STOCKS ON THE MOVE-Domino's Pizza, Voyager, Freshpet